The clinical performance is complex and often involves multiple systemic burdens. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological evaluation.
The platform can help align a team of nationally and internationally authoritative experts to provide accurate diagnosis and treatment programs. Treatment and management of sub-cancerous peripheral neurological disorders require individualized development, typically including multidimensional management, including drug therapy, rehabilitation, and regular follow-up. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological diseases have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions and timely adjusted according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of sub-tumor peripheral neurological diseases. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.